HIGHLIGHTS
- who: Ying Cai et al. from the Newland Biotechnology Co, Ltd, No. , Huoju Road, Weihai, China have published the research: Plant-Derived Exosomes as a Drug-Delivery Approach for the Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer, in the Journal: Pharmaceutics 2022, 822 of /2022/
- how: The results showed that the accumulation of negatively charged liposomes in inflammatory tissue was twice as high as that of neutral or positively charged liposomes . The extracellular microenvironment of tumor cells was acidic (pH 6.5~6.9) and the release performance of Dox-GDNVs was tested . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.